Nootropics News and Research

RSS

Senolytics offer hope for more precise Alzheimer's treatments

A new research paper was published in Aging (Aging-US) on March 29, 2025, as the cover of Volume 17, Issue 3, titled "Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: implications in aging and Alzheimer's disease."

1 Apr 2025

Psilocybin and undisclosed ingredients found in popular mushroom gummies

Mushroom gummies being sold to promote brain function may contain the illegal hallucinogen psylocibin and other harmful ingredients not listed on the label, UVA Health experts are warning after five people – including a 3-year-old child – were sickened.

18 Jul 2024

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.

28 May 2024

Is adult ADHD associated with an increased risk of dementia?

The associations between adult attention-deficit/hyperactivity disorder (ADHD) and the risk of cognitive decline.

19 Oct 2023

Active compound in Lion’s Mane mushroom improves nerve growth and memory

Scientists report that the active compound from an edible mushroom, Hericium erinaceus, can enhance nerve growth and boost memory.

13 Feb 2023

Stimulant users more likely to drink heavily and use other drugs, study finds

College students who misuse stimulant drugs or nootropics like Adderall or Ritalin are also likely to drink heavily and use other drugs, according to new research from the University of Georgia.

28 Sep 2021

Researchers define key questions to help the UK government for next biosecurity threat

During the summer of 2019, a global team of experts put their heads together to define the key questions facing the UK government when it comes to biological security.

4 Feb 2021

Piracetam - an unapproved drug, found in brain supplements

The market is flooded by supplements that claim to boost brain power and stave off dementia. Some of these supplements may not be harmless finds a study. These supplements have been found to contain high portions of an unapproved drug called Piracetam. The study titled, “Presence of Piracetam in Cognitive Enhancement Dietary Supplements,” was published this week in the JAMA Internal Medicine.

26 Nov 2019

Scientists design two AI algorithms to improve early detection of cognitive impairment

Researchers of the Pharmacy and Mathematics departments of the CEU UCH university in Valencia have collaborated in the design of two artificial intelligence algorithms that improve the screening of positive cases in the early detection of cognitive impairment in chemists.

17 Jan 2019

BGRF announces publication of research into personalising nootropic drugs using in silico prediction methods

The Biogerontology Research Foundation (BGRF), a UK-based charity committed to the support of aging research to address the challenges of a rapidly aging population and to reduce the impact of disease on future generations, announces the publication of research into personalising nootropic drugs using in silico prediction methods.

17 Feb 2015